Clareon Toric Single Arm Study (T2-T9)
Status: Active_not_recruiting
Location: See all (6) locations...
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Able to understand and sign the informed consent form.
• Willing and able to attend all scheduled study visits as required per protocol.
• Cataract in one or both eyes with planned extraction by conventional phacoemulsification.
• Astigmatism in the operative eye(s).
• Other protocol-defined inclusion criteria may apply.
Locations
Other Locations
Canada
Laurentians Eye Institute
Boisbriand
Gimbel Eye Centre
Calgary
Uptown Eye Specialists
Concord
Bellevue
Montreal
McGill University
Montreal
Prism Eye Institute
Oakville
Time Frame
Start Date: 2024-04-10
Completion Date: 2028-07
Participants
Target number of participants: 129
Treatments
Experimental: Clareon Toric IOL
Clareon Toric IOL implanted in one or both eyes during cataract surgery
Related Therapeutic Areas
Sponsors
Leads: Alcon Research